Background
==========

More than 250 complete bacterial genome sequences are now available, providing unprecedented opportunities for investigating gene and protein functions \[[@B1]\]. The introduction of errors at the first stage of genome sequencing and gene prediction has a major impact on all subsequent studies. One source of errors in genome annotation is the sequence itself. The development of programs identifying position-specific errors has considerably increased the quality of genomic sequences \[[@B2]-[@B4]\]. These errors may introduce stop codons or \'artificial\' frameshifts in the coding region that are easily detected by computer-assisted methods \[[@B5]-[@B7]\]. Such sequence errors lead to errors in annotation and comparison. An *in silico*survey of the published bacterial genomes shows that most contain interrupted coding sequences (ICDSs) \[[@B5]-[@B7]\]. They occur at low frequency, between 2 and 258 per Mb, not correlated with the size or GC content of the genome. A mean of 74 ICDSs were identified per prokaryotic genome tested \[[@B5]\]. If this is translated into ICDSs per total coding sequences, a figure of 1% to 5% is obtained, with similar figures reported by various independent studies \[[@B5],[@B8]\]. The only notable exception is *Mycobacterium leprae*, which has 30% ICDSs, frequently described as pseudogenes \[[@B8]\]. ICDSs may be present in genes of known or unknown function. A number of bacterial species are known to have developed sophisticated mechanisms for bypassing frameshifts and restoring the correct reading frame, but such mechanisms are unlikely to be general \[[@B9],[@B10]\]. Moreover, the frameshifts bypassed by the ribosome are generally preceded by a unique sequence that can be identified \[[@B11]\]. Thus, the detected ICDSs may either reflect the real genome sequence of the organism, with all the ensuing consequences for the composition of the encoded protein, or they may result from sequencing errors.

We used *M. smegmatis*mc^2^155 as the model species for this study. This saprophytic bacterium, which is often used as a model organism for studies of *M. tuberculosis*functions, has recently been sequenced \[[@B12]\]. By resequencing the ICDSs of this strain, we show that the genome sequence of this organism contains multiple errors. We systematically corrected the errors, and in all cases, these corrections rendered the predicted protein more similar to its ortholog. We also confirm, by a combined proteome and mass spectrometry analysis, that the sequences of some proteins have been incorrectly predicted due to sequencing errors. However, several ICDSs do correspond to true frameshifts. Authentic frameshifts provide a positive addition to our knowledge and make it possible to investigate gene and protein function, whereas sequencing errors generate false knowledge and confound comparative analyses. We show here that the individual analysis of ICDSs can lead to re-evaluation of the annotation of the genome and the proteome. We suggest that each bacterial ICDS should be investigated individually to ascertain its status and to produce a genome sequence suitable for productive comparative genomics.

Results
=======

ICDSs in *M. smegmatis*mc^2^155: a resequencing analysis
--------------------------------------------------------

An *in silico*analysis of the genome of *M. smegmatis*mc^2^155 revealed that it contains 94 ICDSs \[[@B5]\]. The ICDS database was created using a program based on the analysis of physically adjacent genes to predict putative ICDSs in complete genomes. Briefly, pairs of adjacent genes with at least one common homolog are defined as \'coding sequences (CDSs) containing common hits\' and may correspond to a pair of adjacent paralogs or ICDSs. We excluded paralogs from the analysis by searching for sequence similarity between the two \'CDSs containing common hits\'. The remaining CDSs are considered to be ICDSs, indicating frameshifts or in-frame stop codon insertion, due to sequencing errors or authentic events. These 94 ICDSs account for 1.4% of the total coding capacity of this organism. They may result from mutations acquired during evolution or from errors in genome sequencing.

We resequenced the genome of this strain to determine the status of these ICDSs. We did not resequence 21 ICDSs due to the duplication of some open reading frames (ORFs) or high levels of paralogy. The remaining 73 ICDSs were amplified and sequenced on both strands. We compared the nucleotide sequences obtained with the publicly available genome sequence of *M. smegmatis*mc^2^155. We found that 28 of the 73 ICDSs investigated correspond to sequencing errors (Table [1](#T1){ref-type="table"}). These 28 genes containing sequencing errors correspond to 4 errors per megabase in the complete genome. In most cases, correction of the error reunified two adjacent ORFs, resulting in a single ORF rather than the two small ORFs of the original sequence (Figure [1](#F1){ref-type="fig"}).

Three types of error can be distinguished: miscall, overcall and undercall (Table [1](#T1){ref-type="table"}) \[[@B2]-[@B4]\]. However, no miscalls (incorrect prediction of a specific nucleotide at a given position) were observed within the 28 sequences containing errors, due to the nature of the program used. The predicted amino acid sequences derived from the corrected nucleotide sequences differed greatly from the original predicted sequences and, in all cases, were systematically more similar to their orthologs. In one case (ICDS0089), the ORF containing the frameshift was not even predicted; the frameshift was probably responsible for the non-assignment of this ORF. The genes affected by the sequencing errors encode proteins of several classes, including \'unknown\', \'intermediary metabolism\', \'regulation\' and \'lipid metabolism\' (Table [1](#T1){ref-type="table"}). The genes containing frameshifts encode proteins of several classes, including all of those cited above (Table [2](#T2){ref-type="table"}). No particular pattern of nucleotides was associated with the 28 sequences containing errors or with the 45 sequences containing frameshifts.

As *M. smegmatis*mc^2^155 was derived from strain ATCC607, we carried out a comparative analysis of the ICDSs in these two strains. The mc^2^155 strain was generated from ATCC607 by selection for adaptation to genetic manipulation \[[@B13]\]. The mc^2^155 strain differs phenotypically from its progenitor (ATCC607) in several ways \[[@B13],[@B14]\]. The frameshifts in mc^2^155 may well have been acquired recently in the laboratory, due either to counter-selection of pathways of little utility or selection for genetic manipulability. We therefore investigated whether the genes containing frameshifts were acquired before or after the divergence of the two strains. The genome of the ATCC607 strain has not been sequenced, but as both strains belong to the same species (*M. smegmatis*), the sequencing primers originally designed for the mc^2^155 strain could also be used for the ATCC607 strain. We resequenced the 45 genes containing a frameshift of mc^2^155 strain in ATCC607 (Table [2](#T2){ref-type="table"}). All these genes but one (ICDS0020) also contain a frameshift in the progenitor (ATCC607), suggesting that these mutations were acquired before the divergence of the two strains. Thus, the selection of the mc^2^155 strain and its repeated culture in laboratory conditions had no major impact on frameshift acquisition and pseudogene formation.

Our analysis shows that the genome sequence of *M. smegmatis*mc^2^155 contains ICDSs, some of which correspond to authentic mutations acquired during evolution, with others resulting entirely from sequencing errors. Our results show that 18 predicted genes do not actually exist in this species (due to fusion of the two ORFs following the correction of the errors) and that one gene was even not predicted in the former sequence, presumably due to these sequencing errors. In all cases, the new predicted genes are actually more similar than previously thought to orthologs in other species.

ICDSs in *M. smegmatis*mc^2^155: a proteome analysis
----------------------------------------------------

As ICDSs (corresponding to authentic events or to sequencing errors) accounted for 1.4% of the ORF content *of M. smegmatis*mc^2^155, we surveyed a fraction of the proteome to determine the percentage of proteins originating from ORFs not predicted due to misannotations. We carried out two-dimensional electrophoresis of a soluble protein extract. The major spots (120) were excised, digested and analyzed by nano-LC-MS-MS (nanoflow liquid chromatography coupled to tandem mass spectrometry). We were able to identify about 250 proteins unambiguously by comparing the MS-MS data obtained from the tryptic peptides. We compared these MS-MS data directly with public nucleotide sequences, rather than using the classic comparison of MS-MS data with protein sequences \[[@B15],[@B16]\] to prevent the introduction of bias. The identification of several proteins for a single spot is not surprising and has been widely reported in proteomic analysis \[[@B17]\]. For four spots the tryptic peptides identified by nano-LC-MS-MS analysis matched two contiguous hypothetical ORFs each (Table [3](#T3){ref-type="table"}, Figure [2](#F2){ref-type="fig"}). There are two possible explanations for this finding. Firstly, two different proteins, encoded by two different frames in the same genome region, may be present in the same two-dimensional gel electrophoresis spot. This is unlikely, due to differences in molecular masses (Table [3](#T3){ref-type="table"}), but cannot be entirely excluded. Secondly, these peptides may be derived from the same protein. In this case, a bypassed stop codon or a sequencing error could account for such an observation.

For the four proteins concerned, MS-BLAST showed that all the tryptic peptides identified matched the same protein on the basis of sequence similarity with other organisms. We carried out a new search with the MS-MS data obtained for the four two-dimensional gel electrophoresis spots using the corrected sequences obtained after resequencing of all the ICDSs. For all four spots the peptides were found to match in the same frame and new peptides from the proteins were detected (Table [3](#T3){ref-type="table"}, Figure [2](#F2){ref-type="fig"}). We can conclude, therefore, that the four ICDSs detected were due to sequencing errors. These ICDSs are ICDS0019, ICDS0039, ICDS0040 and ICDS0093. We show ICDS0040 as an example in Figure [2](#F2){ref-type="fig"}.

Thus, proteome analysis identified errors in sequences that were not predicted to correspond to an ORF. All four cases detected in this way were found to correspond to sequencing errors (Table [1](#T1){ref-type="table"}). There is, therefore, strong congruence between *in silico*data and nucleotide and proteomic analyses.

Discussion
==========

Previous *in silico*analyses have shown that all bacterial species contain ICDSs in their genome \[[@B5]\]. Here, using *M. smegmatis*and two experimentally independent approaches, we show that these ICDSs correspond to authentic mutations and to sequencing errors. By contrast, a recent large-scale proteome analysis (more than 900 proteins) of *M. smegmatis*mc^2^155 provided no evidence of sequencing errors \[[@B18]\]. Statistically, 16 sequencing errors should have been detected. Possible explanations for this discrepancy are that, by chance, no protein corresponding to an ICDS was extracted, or that proteins in conflict with genomic data were excluded from the analysis.

True frameshifts provide positive information, useful for characterization of the variation of amino acid sequences between various orthologs, whereas sequencing errors introduce noise and create artifactual genetic differences between strains and species. These sequencing errors may result from under-representation of the region in the genomic library or structures making sequencing difficult. Although most genomes have been sequenced with eight-fold coverage (each nucleotide being sequenced eight times), the sequences generated remain a statistical estimation and many regions of low coverage (less than three-fold) still exist in genome sequences \[[@B19]\]. No assembly data are available for the *M. smegmatis*genome project, but the sequencing errors are probably located in such low-coverage regions. In *M. smegmatis*mc^2^155, 28 of the 73 re-sequenced ICDSs were shown to result from errors. The correction of these errors modified the predicted amino acid sequences of the corresponding proteins. These changes in amino acid sequence increased similarity to orthologs, with consequences for comparative genomics. Unfortunately, it was not possible to associate a particular sequence or stretch of nucleotides with sequence errors. It is, therefore, not possible to predict whether a given ICDS corresponds to an authentic event or to a sequence error. The nature of each ICDS must, therefore, be investigated individually.

Modern biology approaches based on massive sequence comparisons need accurate sequences for meaningful analyses of genetic differences and similarities. Re-sequencing and the correction of errors in genomic sequences are likely to lead to the identification of new protein sequences. For instance, in *M. leprae*, which has a large number of ICDSs in its genome (845), even a small proportion of sequencing errors will provide researchers with substantial numbers of new protein sequences, making it possible to identify new functional genes, or to develop new serological tests.

Other mycobacterial species also contain ICDSs in their genome, some of which have been shown to correspond to authentic mutations acquired during evolution. For instance, the genomes of *M. tuberculosis*H37Rv, *M. tuberculosis*CDC1551 and *M. bovis*contain 96, 123 and 111 ICDSs, respectively, corresponding to about 2% of total gene content in each case \[[@B5]\]. Interestingly, a number of ICDSs corresponding to authentic events have been fortuitously characterized. In several cases it has been shown that these events inactivate the gene. For instance, ICDS0066 of *M. tuberculosis*H37Rv, corresponding to a gene encoding a polyketide synthase (*pks1*), includes a frameshift, generating two distinct ORFs, *pks1*and *pks15*. In contrast, *M. bovis*and *M. leprae*carry a *pks1*gene with no frameshift. The complementation of *M. tuberculosis*with the *pks1*of *M. bovis*leads to the synthesis of a new metabolite, phenolphthiocerol \[[@B20]\]. Thus, *M. tuberculosis*has clearly lost the ability to synthesize phenolphthiocerol due to a frameshift within the *pks1*gene. Another example is ICDS0067 in *M. bovis*, which occurs in a sequence encoding a putative glycosyltransferase. The ortholog of this gene has no frameshift in *M. tuberculosis*(Rv2958) \[[@B21]\]. The complementation of *M. bovis*BCG with Rv2958 from *M. tuberculosis*leads to the accumulation of a new product in this strain: diglycosylated phenolglycolipid \[[@B21]\]. Thus, *M. bovis*has lost the ability to metabolize the diglycosylated phenolglycolipid due to the frameshift within the glycosyltransferase gene.

These two examples, taken from published work, illustrate that, as expected, a frameshift within ORF may lead to a loss of function. It should be noted that the genes for which function has been lost (such as *pks1*or *Rv2958*) have been split into only two pieces and could, therefore, theoretically revert to the wild-type allele with ease. These genes containing frameshifts are in the process of becoming pseudogenes (pseudogenization) but need to acquire additional mutations before they are fixed, leading to an almost irreversible loss of function.

The conclusion of this work may be extended to most, if not all, bacterial genomes sequenced to date. These findings have major implications for comparative genomics. Firstly, the resolution of sequencing errors reduces protein variability, facilitating the precise definition of module composition and function. Secondly, as ICDSs corresponding to authentic mutations probably lead to a loss of protein function, the choice of strain or species is of particular importance for investigations of the function of a particular gene. Researchers should carefully consider their investment before creating mutants in these ORFs or producing the corresponding polypeptides. It should be noted that a small number of ORFs containing frameshifts may retain their function or even lead to the acquisition of a new function. It would be interesting to re-frame these ORFs to evaluate the impact on protein function.

We have shown here that 28 of the 73 ICDSs resulted from sequencing errors. It seems highly likely that all sequenced genomes contain ICDSs resulting from sequencing errors. The current ICDS database contains more than 6,600 ICDSs (in 120 genomes) awaiting characterization. In this study, we detected sequencing errors at a rate of 4 per megabase. The calculated number of ICDSs is obviously an underestimate of the reality as some events such as fusion or fission that maintain the correct frame are not detected by the algorithm used \[[@B5]\].

Very few articles have dealt with sequence fidelity. TIGR has reported an error rate for finished genomes of 1 in 88,000 nucleotides \[[@B22],[@B23]\] whereas Weinstock \[[@B19]\] estimated that the frequency of error was between 10^-3^and 10^-5^. The frequency of errors clearly depends on the chemical system used and the research centers carrying out the sequencing work \[[@B24]\]. The development of error prediction programs has greatly helped to reduce the error rate \[[@B2]-[@B4]\]. However, as shown in this study, sequencing errors are clearly a persistent problem in genomic databases. The major problem is that the bioinformaticians who assemble genomes have, for years, discarded precious information about how all the individual sequence fragments align on the assembled chromosome. The only way to test the nature of the ICDSs is to re-sequence the fragment. The NCBI has recently developed the \'Assembly Archive\', which stores records of both the way in which a particular assembly was constructed and alignments of any set of traces to a reference genome \[[@B25]\]. This resource makes it possible to determine whether an ICDS corresponds to a region of low coverage and to evaluate the quality of the raw data. It would clearly be easier to resolve the ICDSs in various genomes if all the sequencing centers made complete assembly data available.

Materials and methods
=====================

Bacterial strains
-----------------

*M. smegmatis*mc^2^155 (ATCC700084) and *M. smegmatis*NRRL B-692 (Trevisan) Lehman and Neumann (ATCC607) were purchased from the American Type Culture Collection (Manassas, Virginia, USA).

ICDS detection in *M. smegmatis*mc^2^155
----------------------------------------

The genome sequence of *M. smegmatis*mc^2^155 was taken from the TIGR website \[[@B12]\]. The ICDSs were detected using the method developed by Perrodou *et al*. \[[@B5]\].

Primer design and sequence analysis
-----------------------------------

The primers used to sequence frameshifts were designed as previously described \[[@B5]\] using an optimized version of the CADO4MI program (Computed Assisted Design of Oligonucleotides for Microarray). It is a freeware (GNU General Public License) accessible online \[[@B26]\]. For each genome, sequencing primers are available online \[[@B27]\]. The chromosomal DNA of the mc^2^155 and ATCC607 strains of *M. smegmatis*used for PCR amplification was purified as previously described \[[@B28]\]. Pairs of primers were used for amplification with Pfu Turbo DNA polymerase (Stratagene, La Jolla, CA, USA). PCR samples were run on a 0.8% agarose gel and the fragments were excised from the gel and purified using the QIAquick Gel purification kit (Qiagen Chatsworth, CA, USA). The PCR fragments had a mean length of 300 base-pairs. Purified PCR fragments were used as templates in sequencing reactions with each primer used for PCR amplification. The nucleotide and inferred aminoacid sequences were analyzed with DNA Strider \[[@B29]\]. Three independent amplicons were sequenced for each ICDS.

Protein extraction and two-dimensional gel electrophoresis
----------------------------------------------------------

*M*. *smegmatis*strain mc^2^155 (1 liter) was grown in M9 minimal medium (Difco, Detroit, USA) for 5 days and then centrifuged. Bacterial pellets were used for two-dimensional electrophoresis. Unless otherwise specified, all chemicals were obtained from Sigma (St Louis, MO, USA). Dithiothreitol (DTT) and iodoacetamide were obtained from Fluka (Buchs, Switzerland). The pellet fraction was incubated with extraction buffer (50 mM Tris, pH7.5, 1 mM phenylmethylsulfonyl fluoride, 1 mM EDTA, 1 mM DTT, protease inhibitor mixture (complete from Roche, Basel, Switzerland)) for 45 minutes at 4°C. The mixture was sonicated for a few seconds and its protein concentration determined by Bradford assay. The solvent of the protein extract was evaporated off and the protein residue was suspended in rehydration buffer (8 M urea, 2 M thiourea, 4% 3- \[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonic acid, 0.5% Triton X-100, 1% DTT, 20 mM spermine, 2% Pharmalyte (Amersham Pharmacia Biotech, Piscataway, NJ, USA)). The sample was incubated for 30 minutes at 20°C and centrifuged at 15,000 rpm at 20°C.

Protein extract was run on a strip of gel of pH range 3 to 10 (Bio-Rad Laboratories, Hercules, CA, USA) for 15 h at 20°C under 50 V in a PROTEAN isoelectric focusing cell (Bio-Rad). Isoelectric focusing was carried out with several voltage steps: 1 h at 200 V, then 4 h at 1,000 V followed by 16 h at 5,000 V and finally 7 h at 500 V at 20°C. The strips were incubated for 30 minutes at 20°C in electrophoresis buffer (50 mM Tris-HCl, pH 8.8, 6 M urea, 30% (v/v) glycerol, 2% (w/v) SDS, and 1% DTT), followed by 30 minutes in the same buffer supplemented with 2.5% iodoacetamide. Electrophoresis in a gradient gel (5% to 20% acrylamide) on a PROTEAN II (Bio-Rad) apparatus at 5 mA for 1 h and 10 mA overnight was used as the second dimension. The gel was stained with Colloidal blue (G260, Sigma); 120 spots were selected by visual inspection and gel slices were excised with a Proteineer SP automated spot picker (Bruker Daltonics, Bremen, Germany) according to the manufacturer\'s instructions.

Mass spectrometry
-----------------

The two-dimensional gel spots were excised, washed, destained, reduced, alkylated and dehydrated for in-gel digestion of the proteins with an automated protein digestion system, MassPREP Station (Waters, Milford, MA, USA). The proteins were digested overnight at room temperature with trypsin. They were then extracted with 60% (v/v) acetonitrile in 5% (v/v) formic acid and then with 100% acetonitrile. The resulting peptide extracts were analyzed directly by nano-LC-MS-MS on an Agilent 1100 Series capillary LC system (Agilent Technologies, Palo Alto, USA) coupled to an HCT Ultra ion trap (Bruker Daltonics). This instrument was equipped with a nanospray ion source and chromatographic separation was carried out on reverse phase (RP) capillary columns (C18, 75 μm id, 15 cm length, Agilent Technologies) with a flow rate of 200 nl/minute. The voltage applied to the capillary cap was optimized to -2,000 V. MS-MS scanning mode was performed in the Ultra Scan resolution mode at a scan rate of 26,000 m/z per second. Eight scans were averaged to obtain an MS-MS mass spectrum. The complete system was fully controlled by Agilent ChemStation and EsuireControl (Bruker Daltonics) software. The generated peak-lists of fragments were used for public *M. smegmatis*genome database searches.
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![Scheme for ICDS detection and resolution strategy. **(a)**ICDSs are detected within the genome by *in silico*analysis. The double daggers (‡) indicate the regions containing the identified frameshift. Upon resolution by sequencing and mass spectrometry analysis, the ICDSs can be classified as **(b)**true frameshifts or **(c)**sequencing errors. The hash symbol (\#) indicates the region of the ORF containing the frameshift. The asterisks (\*) indicate sites of corrected sequencing errors resulting in the reconstitution of a full-length ORF. The ORFs are depicted with arrows. The ORF may or may not be in the same frame. Proteins are represented by ellipses.](gb-2007-8-2-r20-1){#F1}

![Comparison of genomic prediction with proteomic results (example of ICDS0040). **(a)**Representation of the DNA region and its predicted ORFs (in color). **(b)**Detailed view of the two-dimensional gel. Nano-LC-MS-MS data are obtained after extraction and digestion of the protein. The matching peptides are boxed in the translated genomic sequence (a,c). **(c)**Representation of the DNA region and its predicted ORF upon correction of the sequencing errors (depicted in the ellipse). Correction of the sequencing errors reassociates the two peptides to give a single protein, accounting for their appearance at a single spot.](gb-2007-8-2-r20-2){#F2}

###### 

ICDSs shown by resequencing to correspond to sequencing errors in *M. smegmatis*mc^2^155

  ICDS number   5\' position   ORF number   Putative function                    Functional classification   Accession number       Type of event
  ------------- -------------- ------------ ------------------------------------ --------------------------- ---------------------- ---------------
  0012          1639371        1547         Hypothetical                         Unknown                     [DQ866846](DQ866846)   U
  0019          1918521        1842-1843    Adenosylhomocysteinase               Intermediary metabolism     [DQ866847](DQ866847)   U
  0022          1930746        1854-1855    Sodium/proton antiporter             Cell wall, process          [DQ866848](DQ866848)   U
  0024          2055797        1975-1976    Methane/phenol/toluene hydroxylase   Intermediary metabolism     [DQ866849](DQ866849)   O
  0026          2119141        2042         Conserved hypothetical               Unknown                     [DQ866850](DQ866850)   O
  0027          2162020        2086-2087    Ferredoxin-NADP reductase            Intermediary metabolism     [DQ866851](DQ866851)   O
  0028          2221312        2149-2150    Hypothetical                         Unknown                     [DQ866852](DQ866852)   U
  0030          2290855        2215-2216    CoA-transferase                      Intermediary metabolism     [DQ866853](DQ866853)   O
  0035          2799279        2732-2733    Conserved hypothetical               Unknown                     [DQ866854](DQ866854)   U
  0039          3216877        3151         Aconitate hydratase                  Intermediary metabolism     [DQ866855](DQ866855)   O (× 2)
  0040          3262835        3192-3193    Maltooligosyltrehalose synthase      Intermediary metabolism     [DQ866856](DQ866856)   U
  0041          3313327        3240         ABC transporter (CydC)               Intermediary metabolism     [DQ866857](DQ866857)   O
  0051          3902349        3837         Dephospho-CoA kinase                 Intermediary metabolism     [DQ866858](DQ866858)   O (× 2)
  0053          3961899        3892-3893    Transcriptional regulator            Regulation                  [DQ866859](DQ866859)   O
  0054          4017126        3952-3953    Hypothetical                         Unknown                     [DQ866860](DQ866860)   O
  0057          4255762        4183         Pyruvate dehydrogenase               Intermediary metabolism     [DQ866861](DQ866861)   U
  0058          4288648        4211-4212    Nitrate reductase                    Intermediary metabolism     [DQ866862](DQ866862)   U
  0061          4637174        4539-4540    Oxidoreductase                       Intermediary metabolism     [DQ866863](DQ866863)   O
  0072          5644787        5533-5534    Hypothetical                         Unknown                     [DQ866864](DQ866864)   U
  0073          5855980        5754         Acetyltransferase                    Intermediary metabolism     [DQ866865](DQ866865)   O
  0076          6078397        5970-5971    Fatty-acid CoA synthetase            Lipid metabolism            [DQ866866](DQ866866)   U
  0080          6600510        6504-6505    Conserved hypothetical               Unknown                     [DQ866867](DQ866867)   U
  0082          6670969        6579         Helicase                             DNA metabolism              [DQ866868](DQ866868)   O
  0083          6673489        6581         Hypothetical                         Unknown                     [DQ866869](DQ866869)   U
  0089          342400         \*           Methyltransferase                    Intermediary metabolism     [DQ866870](DQ866870)   U
  0091          601272         0511-0512    Hypothetical                         Unknown                     [DQ866871](DQ866871)   U
  0092          809979         0716-0717    Transcriptional regulator            Regulation                  [DQ866872](DQ866872)   U
  0093          428949         1395-1396    Elongation factor G                  Translation                 [DQ866873](DQ866873)   O

The nucleotide position, the affected ORF (according to the TIGR website), its putative function computed after the correction of the sequencing errors, its functional classification and its accession number are indicated for each ICDS. The asterisk indicates an ORF not predicted by TIGR. Two types of error were observed: overcall (O), an extra nucleotide not present in the target sequence was initially predicted at a given position; and undercall (U), a nucleotide corresponding to a true target sequence was not predicted at a given position.

###### 

ICDSs shown by resequencing to correspond to authentic mutations in both *M. smegmatis*mc^2^155 and ATCC607

  ICDS number   5\' position   ORF number   Putative function                               Functional classification
  ------------- -------------- ------------ ----------------------------------------------- ---------------------------
  0003          1169121        1094-1095    Oxidoreductase                                  Intermediary metabolism
  0004          1232918        1164-1165    Arsenic resistance protein                      Cell wall, process
  0005          1277324        1200-1201    Glycosyltransferase                             Intermediary metabolism
  0006          1304141        1226-1227    ABC transporter (permease)                      Cell wall, process
  0007          1508649        1403-1404    Sodium/proton antiporter                        Cell wall, process
  0008          1510156        1405-1406    Arginine/ornithine antiporter                   Cell wall, process
  0009          1510156        1405-1407    Arginine/ornithine antiporter                   Cell wall, process
  0010          1510315        1406-1407    Arginine/ornithine antiporter                   Cell wall, process
  0011          1545509        1447         Secreted immunogenic protein (Mpt70)            Cell wall, process
  0013          1645546        1552-1553    Conserved hypothetical                          Unknown
  0014          1650143        1557-1558    Hypothetical                                    Unknown
  0015          1669043        1575-1576    Hypothetical                                    Unknown
  0020          1922875        1848-1849    Formate dehydrogenase, alpha subunit            Intermediary metabolism
  0021          1924487        1849         Formate dehydrogenase, alpha subunit            Intermediary metabolism
  0023          2026072        1949-1950    Hypothetical                                    Unknown
  0025          2097821        2019-2020    Cytochrome P450                                 Intermediary metabolism
  0029          2234814        2164-2165    Substrate-CoA ligase                            Lipid metabolism
  0033          2557504        2472-2473    Sugar transporter                               Cell wall, process
  0036          2877071        2816-2817    Two-component system regulator                  Cell wall, process
  0038          3161135        3097-3098    O-methyltransferase                             Intermediary metabolism
  0042          3351460        3281-3282    Sugar ABC transporter                           Cell wall, process
  0043          3410192        3341         Fatty acid desaturase (DesA3)                   Lipid metabolism
  0044          3442071        3378         Dehydrogenase/reductase                         Intermediary metabolism
  0045          3471038        3405-3406    Hypothetical                                    Unknown
  0046          3506575        3443-3344    Hypothetical                                    Unknown
  0049          3849109        3785         Conserved hypothetical                          Unknown
  0052          3930423        3862-3863    Polyprenol-monophosphomannose synthase (Ppm1)   Cell wall, process
  0055          4172910        4102-4103    Dehydrogenase                                   Intermediary metabolism
  0059          4551995        4464-4465    Hypothetical                                    Unknown
  0063          5113475        5001         Transporter                                     Cell wall, process
  0064          5127828        5017-5018    Multidrug resistance efflux protein (Tap)       Cell wall, process
  0067          5238606        5122-5123    Nitrate reductase (NarX)                        Intermediary metabolism
  0070          5596138        5488         Conserved hypothetical                          Unknown
  0071          5639815        5527-5528    Protein-glutamate methylesterase                Intermediary metabolism
  0074          6014123        5909-5910    Hypothetical                                    Unknown
  0075          6071755        5963-5964    Integral membrane protein                       Unknown
  0078          6147983        6046         AraC-family transcriptional regulator           Regulation
  0079          6260084        6152-6153    Anion transporter                               Cell wall, process
  0084          6846273        6761         Oxidoreductase                                  Intermediary metabolism
  0085          6862121        6775         Major facilitator transporter                   Cell wall, process
  0086          6955671        6870-6871    Glutamine transporter                           Cell wall, process
  0087          6977889        6889-6890    Thioredoxin                                     Intermediary metabolism
  0088          17247          0017-0018    Hypothetical                                    Unknown
  0094          3456823        \*           Dihydrolipoamide dehydrogenase                  Intermediary metabolism

The nucleotide position, the affected ORF (according to the TIGR website), its putative function and its functional classification are indicated for each ICDS. The asterisk indicates an ORF not predicted by TIGR.

###### 

ICDSs shown by nano-LC-MS-MS analysis to correspond to sequencing errors in *M. smegmatis*mc^2^155

  ICDS number   Affected ORF   Calculated mass before correction   Calculated mass after correction
  ------------- -------------- ----------------------------------- ----------------------------------
  0019          1842-1843      45,980-7,370                        53,460
  0039          3151           64,570                              101,200
  0040          3192-3193      48,730-33,880                       83,490
  0093          1395-1396      21,560-63,800                       77,220

The affected ORFs (according to the TIGR website) and their predicted molecular weights before and after genomic correction are indicated.
